Abstract

IntroductionDyslipidaemia contributes to the occurrence of colorectal cancer (CRC). We hypothesized that qualitative changes of lipoproteins are associated with the risk for CRC development. This study analyses low-density lipoprotein (LDL) and high-density lipoprotein (HDL) diameters, as well as distribution of LDL and HDL subclasses in patients with CRC, with an aim to determine whether advanced lipid testing might be useful in predicting the risk for the onset of this malignancy.Materials and methodsThis case-control study included 84 patients with newly diagnosed CRC and 92 controls. Gradient gel electrophoresis was applied for separation of lipoprotein subclasses and for LDL and HDL diameters determination. Lipid parameters were measured using routine enzymatic methods.ResultsTotal cholesterol, HDL and LDL-cholesterol were significantly lower in CRC patients compared to controls (4.47 mmol/L vs. 5.63 mmol/L; 0.99 mmol/L vs. 1.27 mmol/L; 2.90 mmol/L vs. 3.66 mmol/L; P < 0.001, respectively). Patients had significantly smaller LDL (25.14 nm vs. 26.92 nm; P < 0.001) and HDL diameters (8.76 nm vs. 10.17 nm; P < 0.001) and greater proportion of small, dense LDL particles (54.0% vs. 52.9%; P = 0.044) than controls. Decreased LDL and HDL diameters were independent predictors of CRC (OR = 0.5, P = 0.001 and OR = 0.5, P = 0.008, respectively), and alongside with age and HDL-cholesterol concentrations formed the optimal cost-effective model, providing adequate discriminative abilities for CRC (AUC = 0.89) and correct patients classification (81%).ConclusionsPatients with CRC have decreased LDL and HDL diameters and increased proportion of smaller particles. LDL and HDL diameters determination could be useful in assessing the risk for CRC development.

Highlights

  • Dyslipidaemia contributes to the occurrence of colorectal cancer (CRC)

  • Total cholesterol, high-density lipoprotein (HDL) and low-density lipoprotein (LDL)-cholesterol were significantly lower in CRC patients compared to controls (4.47 mmol/L vs. 5.63 mmol/L; 0.99 mmol/L vs. 1.27 mmol/L; 2.90 mmol/L vs. 3.66 mmol/L; P < 0.001, respectively)

  • Decreased LDL and HDL diameters were independent predictors of CRC (OR = 0.5, P = 0.001 and odds ratio (OR) = 0.5, P = 0.008, respectively), and alongside with age and HDL-cholesterol concentrations formed the optimal cost-effective model, providing adequate discriminative abilities for CRC (AUC = 0.89) and correct patients classification (81%)

Read more

Summary

Introduction

Dyslipidaemia contributes to the occurrence of colorectal cancer (CRC). Colorectal cancer (CRC) is one of the most prevalent malignancies and one of the leading causes of cancer related death worldwide. The precise cause of CRC is still undetermined considering that there are numerous genetic and environmental factors that may contribute to the development of cancer [2]. It has been documented that lipid disequilibrium is one of the main risk factors for CRC, and for various types of cancer such as gastric, prostate, liver, lung, breast, endometrial, head and neck, and hematopoietic cancers [3,4,5]. It has been shown that dyslipidaemia may contribute to the occurrence of CRC, probably through the interaction with process of inflammation, oxidative stress, and insulin resistance [3,6,7].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call